Perform Another (Advanced) Search

1.  Study Posting (912) Trial #27826, Memory Loss, Toledo, OH
...OH Trial Information Alzheimer's Disease Psychologist and Neurologist evaluation, all testing which may include CT Scan or MRI, labs and study medication at no cost and no insurance billed. Stipend payment ...
View Page

2.  Study Posting (912) Trial #27827, Alzheimer's Disease, Toledo, OH
...OH Trial Information Alzheimer's Disease Psychologist and Neurologist evaluation, all testing which may include CT Scan or MRI, labs and study medication at no cost and no insurance billed. Stipend payment ...
View Page

3.  Study Posting (5339) Trial #154698, Metastatic Cancer, Bronx, NY
...and feasible during a 28 day trial in patients with advanced cancer. • To use PET/CT scans at the trial's start and conclusion as a measure of possible efficacy. Protocol Summary ...
View Page

4.  Study Posting (5339) Trial #154292, Cancer Treatment, Bronx, NY
...and feasible during a 28 day trial in patients with advanced cancer. • To use PET/CT scans at the trial's start and conclusion as a measure of possible efficacy. Protocol Summary ...
View Page

5.  Study Posting (4912) Trial #120690, Thymomas, Paramus, NJ
...Biopsy-proven thymoma or thymic carcinoma. • Invasive thymoma determined by specific radiographic criteria determined by CT scan. • Acceptable kidney, liver, bone marrow, and respiratory functions. • Karnofsy performance status greater than 80%. • Patients ...
View Page

6.  Study Posting (4519) Trial #110166, Non-Small Cell Lung Cancer, Melbourne, Australia
...these imaging technologies may be used as surrogate efficacy markers. Patients will undergo PET and CT scans at screening; eligible patients will then receive Tarceva (150mg po daily). They will undergo FDG ...
View Page

7.  Study Posting (4519) Trial #113566, Non-Small Cell Lung Cancer, Heidelberg, Australia
...these imaging technologies may be used as surrogate efficacy markers. Patients will undergo PET and CT scans at screening; eligible patients will then receive Tarceva (150mg po daily). They will undergo FDG ...
View Page

8.  Study Posting (4519) Trial #110150, Non-Small Cell Lung Cancer, Chermside, Australia
...these imaging technologies may be used as surrogate efficacy markers. Patients will undergo PET and CT scans at screening; eligible patients will then receive Tarceva (150mg po daily). They will undergo FDG ...
View Page

9.  Study Posting (4519) Trial #110164, Non-Small Cell Lung Cancer, Brisbane, Australia
...these imaging technologies may be used as surrogate efficacy markers. Patients will undergo PET and CT scans at screening; eligible patients will then receive Tarceva (150mg po daily). They will undergo FDG ...
View Page

10.  Study Posting (180) Trial #64207, Non-Hodgkin's Lymphoma, New York, NY
...this study. During this study, patients will have screening tests such as bone marrow examination, CT scanning of chest and abdomen, and blood tests requiring 2 to 3 tablespoons of blood. Blood ...
View Page

11.  Study Posting (77) Trial #143166, Vascular Diseases, New York, NY
...CCTA) Examination (Visipaque Registry Study). This study is being conducted to compare the CCTA scan (CT scan of the heart) results with any heart related problems you may have 1-month, 6 ...
View Page

12.  Study Posting (799) Trial #161735, High Cholesterol (Hyperlipidemia), Boston, MA
...582949 can effectively reduce cholesterol plaque swelling as measured by carotid/aortic FDG- PET and CT scan. This study is being conducted by the Cardiology Division and Radiology Department of the Massachusetts ...
View Page

13.  Study Posting (799) Trial #161726, Atherosclerosis, Boston, MA
...582949 can effectively reduce cholesterol plaque swelling as measured by carotid/aortic FDG- PET and CT scan. This study is being conducted by the Cardiology Division and Radiology Department of the Massachusetts ...
View Page

14.  Study Posting (799) Trial #161734, *Healthy Patient Studies, Boston, MA
...582949 can effectively reduce cholesterol plaque swelling as measured by carotid/aortic FDG- PET and CT scan. This study is being conducted by the Cardiology Division and Radiology Department of the Massachusetts ...
View Page

15.  Study Posting (1918) Trial #161381, Ovarian Cancer, Savannah, GA
...tumor lesion that can be accurately measured in ≥ 1 dimension of ≥ 1.0 cm by CT scan (CT scan slice thickness ≤ 0.5 cm); ≥ 1.0 cm caliper measurement by clinical exam ...
View Page

16.  Study Posting (1918) Trial #161380, Fallopian Tube Cancer, Savannah, GA
...tumor lesion that can be accurately measured in ≥ 1 dimension of ≥ 1.0 cm by CT scan (CT scan slice thickness ≤ 0.5 cm); ≥ 1.0 cm caliper measurement by clinical exam ...
View Page

17.  Study Posting (1918) Trial #158894, Pancreatic Cancer, Savannah, GA
...tumors, duodenal adenocarcinoma, or ampullary adenocarcinoma • Localized, potentially resectable* tumor by chest x-ray or CT scan and abdominal CT scan or MRI, as defined by the following: • No evidence of tumor ...
View Page

18.  Study Posting (1918) Trial #159761, Endometrial Cancer, Savannah, GA
...of extrapelvic disease, including positive periaortic or inguino-femoral nodes by chest x-ray or CT scan • Prior primary surgical debulking (including removal of gross symptomatic disease in the pelvis and/or ...
View Page

19.  Study Posting (4912) Trial #122105, Non-Small Cell Lung Cancer, Paramus, NJ
...Lung nodule suspicious for clinical stage I NSCLC • Mass = 3 cm in maximum diameter by CT scan of the chest and upper abdomen • Clinical stage IA OR selected stage IB with visceral ...
View Page

20.  Study Posting (1918) Trial #158890, Endometrial Cancer, Savannah, GA
...1 unidimensionally measurable lesion ≥ 20 mm by conventional techniques (e.g., palpation, plain x-ray, CT scan, and MRI) or ≥ 10 mm by spiral CT scan • Must have at least one "target ...
View Page